Ixazomib (trade name Ninlaro) is a drug for the treatment of multiple myeloma, a type of white blood cell cancer, in combination with other drugs. It is...
17 KB (1,693 words) - 06:49, 1 July 2024
ciclesonide. On November, the U.S. Food and Drug Administration approved Ixazomib developed by Takeda for use in combination with lenalidomide and dexamethasone...
33 KB (2,778 words) - 01:29, 7 September 2024
pomalidomide), and a proteasome inhibitor (e.g., or bortezomib, carfilzomib or ixazomib), in combination with a steroid (e.g., dexamethasone). While triplet therapies...
131 KB (13,509 words) - 06:14, 3 December 2024
for the treatment of cancer. Drugs such as bortezomib, carfilzomib, and ixazomib are already approved for use in treating multiple myeloma and mantle cell...
14 KB (1,651 words) - 07:54, 9 December 2024
Palbociclib Ribociclib Seliciclib†) PrI Bortezomib Carfilzomib Oprozomib Ixazomib PhI (Anagrelide) IMPDI (Tiazofurin§) LI (Masoprocol) PARP inhibitor (Fuzuloparib...
19 KB (1,757 words) - 09:15, 29 October 2024
Palbociclib Ribociclib Seliciclib†) PrI Bortezomib Carfilzomib Oprozomib Ixazomib PhI (Anagrelide) IMPDI (Tiazofurin§) LI (Masoprocol) PARP inhibitor (Fuzuloparib...
9 KB (613 words) - 05:31, 18 July 2024
Palbociclib Ribociclib Seliciclib†) PrI Bortezomib Carfilzomib Oprozomib Ixazomib PhI (Anagrelide) IMPDI (Tiazofurin§) LI (Masoprocol) PARP inhibitor (Fuzuloparib...
38 KB (3,966 words) - 22:31, 11 November 2024
Palbociclib Ribociclib Seliciclib†) PrI Bortezomib Carfilzomib Oprozomib Ixazomib PhI (Anagrelide) IMPDI (Tiazofurin§) LI (Masoprocol) PARP inhibitor (Fuzuloparib...
31 KB (2,913 words) - 23:49, 9 December 2024
Palbociclib Ribociclib Seliciclib†) PrI Bortezomib Carfilzomib Oprozomib Ixazomib PhI (Anagrelide) IMPDI (Tiazofurin§) LI (Masoprocol) PARP inhibitor (Fuzuloparib...
16 KB (1,138 words) - 06:53, 27 December 2024
Palbociclib Ribociclib Seliciclib†) PrI Bortezomib Carfilzomib Oprozomib Ixazomib PhI (Anagrelide) IMPDI (Tiazofurin§) LI (Masoprocol) PARP inhibitor (Fuzuloparib...
20 KB (1,914 words) - 10:01, 21 December 2024
Palbociclib Ribociclib Seliciclib†) PrI Bortezomib Carfilzomib Oprozomib Ixazomib PhI (Anagrelide) IMPDI (Tiazofurin§) LI (Masoprocol) PARP inhibitor (Fuzuloparib...
26 KB (2,420 words) - 17:03, 13 November 2024
Palbociclib Ribociclib Seliciclib†) PrI Bortezomib Carfilzomib Oprozomib Ixazomib PhI (Anagrelide) IMPDI (Tiazofurin§) LI (Masoprocol) PARP inhibitor (Fuzuloparib...
5 KB (324 words) - 08:56, 9 December 2024
Palbociclib Ribociclib Seliciclib†) PrI Bortezomib Carfilzomib Oprozomib Ixazomib PhI (Anagrelide) IMPDI (Tiazofurin§) LI (Masoprocol) PARP inhibitor (Fuzuloparib...
33 KB (2,971 words) - 01:52, 24 December 2024
Palbociclib Ribociclib Seliciclib†) PrI Bortezomib Carfilzomib Oprozomib Ixazomib PhI (Anagrelide) IMPDI (Tiazofurin§) LI (Masoprocol) PARP inhibitor (Fuzuloparib...
92 KB (12,540 words) - 18:53, 23 December 2024
Palbociclib Ribociclib Seliciclib†) PrI Bortezomib Carfilzomib Oprozomib Ixazomib PhI (Anagrelide) IMPDI (Tiazofurin§) LI (Masoprocol) PARP inhibitor (Fuzuloparib...
17 KB (1,747 words) - 19:53, 17 March 2024
utilized to restore the normal cell lines. There are newer medications (ixazomib, carfilzomib, daratumumab, elotuzumab) under research for the treatment...
30 KB (3,354 words) - 16:25, 7 December 2024
Palbociclib Ribociclib Seliciclib†) PrI Bortezomib Carfilzomib Oprozomib Ixazomib PhI (Anagrelide) IMPDI (Tiazofurin§) LI (Masoprocol) PARP inhibitor (Fuzuloparib...
34 KB (3,077 words) - 05:23, 27 December 2024
Palbociclib Ribociclib Seliciclib†) PrI Bortezomib Carfilzomib Oprozomib Ixazomib PhI (Anagrelide) IMPDI (Tiazofurin§) LI (Masoprocol) PARP inhibitor (Fuzuloparib...
20 KB (1,870 words) - 19:10, 15 December 2024
Palbociclib Ribociclib Seliciclib†) PrI Bortezomib Carfilzomib Oprozomib Ixazomib PhI (Anagrelide) IMPDI (Tiazofurin§) LI (Masoprocol) PARP inhibitor (Fuzuloparib...
6 KB (302 words) - 01:44, 27 August 2024
Palbociclib Ribociclib Seliciclib†) PrI Bortezomib Carfilzomib Oprozomib Ixazomib PhI (Anagrelide) IMPDI (Tiazofurin§) LI (Masoprocol) PARP inhibitor (Fuzuloparib...
80 KB (9,540 words) - 20:14, 5 December 2024
Palbociclib Ribociclib Seliciclib†) PrI Bortezomib Carfilzomib Oprozomib Ixazomib PhI (Anagrelide) IMPDI (Tiazofurin§) LI (Masoprocol) PARP inhibitor (Fuzuloparib...
41 KB (3,764 words) - 13:54, 13 December 2024
Palbociclib Ribociclib Seliciclib†) PrI Bortezomib Carfilzomib Oprozomib Ixazomib PhI (Anagrelide) IMPDI (Tiazofurin§) LI (Masoprocol) PARP inhibitor (Fuzuloparib...
19 KB (1,553 words) - 19:42, 17 May 2024
Palbociclib Ribociclib Seliciclib†) PrI Bortezomib Carfilzomib Oprozomib Ixazomib PhI (Anagrelide) IMPDI (Tiazofurin§) LI (Masoprocol) PARP inhibitor (Fuzuloparib...
49 KB (4,506 words) - 05:25, 2 December 2024
Palbociclib Ribociclib Seliciclib†) PrI Bortezomib Carfilzomib Oprozomib Ixazomib PhI (Anagrelide) IMPDI (Tiazofurin§) LI (Masoprocol) PARP inhibitor (Fuzuloparib...
5 KB (290 words) - 20:59, 6 January 2024
Alitretinoin L01XF03 Bexarotene L01XG01 Bortezomib L01XG02 Carfilzomib L01XG03 Ixazomib L01XH01 Vorinostat L01XH02 Romidepsin L01XH03 Panobinostat L01XH04 Belinostat...
13 KB (935 words) - 04:36, 23 December 2024
Palbociclib Ribociclib Seliciclib†) PrI Bortezomib Carfilzomib Oprozomib Ixazomib PhI (Anagrelide) IMPDI (Tiazofurin§) LI (Masoprocol) PARP inhibitor (Fuzuloparib...
9 KB (556 words) - 06:01, 27 December 2024
Palbociclib Ribociclib Seliciclib†) PrI Bortezomib Carfilzomib Oprozomib Ixazomib PhI (Anagrelide) IMPDI (Tiazofurin§) LI (Masoprocol) PARP inhibitor (Fuzuloparib...
22 KB (2,404 words) - 02:48, 4 September 2023
Palbociclib Ribociclib Seliciclib†) PrI Bortezomib Carfilzomib Oprozomib Ixazomib PhI (Anagrelide) IMPDI (Tiazofurin§) LI (Masoprocol) PARP inhibitor (Fuzuloparib...
14 KB (1,105 words) - 06:03, 14 September 2024
Palbociclib Ribociclib Seliciclib†) PrI Bortezomib Carfilzomib Oprozomib Ixazomib PhI (Anagrelide) IMPDI (Tiazofurin§) LI (Masoprocol) PARP inhibitor (Fuzuloparib...
7 KB (564 words) - 16:04, 9 January 2024
Palbociclib Ribociclib Seliciclib†) PrI Bortezomib Carfilzomib Oprozomib Ixazomib PhI (Anagrelide) IMPDI (Tiazofurin§) LI (Masoprocol) PARP inhibitor (Fuzuloparib...
12 KB (1,314 words) - 05:55, 8 July 2024